GlassScriptPhysician profile
Raul Oviedo
NPI 1972533941
$17,393.95
in general payments reported to CMS, 2019-2025
40 companies · $1,753 in 2025
The $1,753 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,499 · 2020: $1,129 · 2021: $1,679 · 2022: $1,923 · 2023: $5,036 · 2024: $2,375 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,875 · Food and Beverage: $4,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,875.00 |
| Food and Beverage | $4,289.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,875.00 | 2023-2024 | Carto 3 |
| Medtronic, INC. | $2,014.20 | 2021-2025 | Micra, Crome Dr Mri Surescan, Attain Command + Surevalve |
| Abbott Laboratories | $1,599.13 | 2019-2025 | Perclose Prostyle, Ensite, Aveir |
| Biosense Webster, INC. | $1,193.77 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Medtronic Vascular, INC. | $1,191.71 | 2019-2020 | |
| Biotronik INC. | $1,020.88 | 2019-2025 | Biomonitor, Amvia Edge |
| Edwards Lifesciences Corporation | $656.78 | 2022-2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $594.01 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $586.44 | 2019-2025 | Farapulse, Watchman Access System, Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $549.55 | 2019-2024 | |
| Cvrx, INC. | $336.05 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $328.67 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $257.96 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $199.44 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $195.22 | 2019-2025 | Camzyos |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $145.81 | 2019-2023 | Lexiscan |
| Regeneron Healthcare Solutions, INC. | $139.87 | 2019 | |
| Amgen INC. | $128.88 | 2019-2021 | |
| Stryker Corporation | $126.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $117.53 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.65 | 2019-2025 | Jardiance |
| Pfizer INC. | $112.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $95.84 | 2019-2024 | Andexxa |
| Cardiva Medical, INC. | $92.52 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $84.44 | 2025 | |
| Gilead Sciences, INC. | $70.16 | 2019 | |
| Alnylam Pharmaceuticals INC. | $68.15 | 2019-2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $59.57 | 2022-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $59.15 | 2022 | |
| Medtronic USA, INC. | $51.40 | 2019-2020 | |
| Daiichi Sankyo INC. | $48.73 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $46.29 | 2024-2025 | |
| Cleerly, INC. | $41.52 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Amarin Pharma, INC. | $40.18 | 2019-2020 | |
| Cardiofocus, INC. | $38.62 | 2022 | |
| Chiesi USA, INC. | $35.10 | 2019-2022 | |
| Bardy Diagnostics, INC. | $28.00 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.08 | 2023 | Arcalyst |
| Elutia, INC. | $16.04 | 2019 | |
| Medline Industries LP | $15.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Oviedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.